找回密碼
 To register

QQ登錄

只需一步，快速開(kāi)始

掃一掃，訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Experimental and Clinical Progress in Cancer Chemotherapy; Franco M. Muggia (Clinical Director) Book 1985 Martinus Nijhoff Publishers, Bos

[復(fù)制鏈接]
查看: 50124|回復(fù): 42
樓主
發(fā)表于 2025-3-21 18:52:38 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy
編輯Franco M. Muggia (Clinical Director)
視頻videohttp://file.papertrans.cn/319/318964/318964.mp4
叢書(shū)名稱Cancer Treatment and Research
圖書(shū)封面Titlebook: Experimental and Clinical Progress in Cancer Chemotherapy; Franco M. Muggia (Clinical Director) Book 1985 Martinus Nijhoff Publishers, Bos
描述As in CANCER CHEMOTHERAPY 1, this volume brings to the reader highlights in three different areas of cancer therapeutics: new concepts and models; drug classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. Authors were selected on the basis of their ability to provide a critical overview of specific subjects and their involvement in original work. I shall review the aims of this second volume, and then elaborate on the scope of its con- tents. The principal aim of the volumes on cancer chemotherapy in the‘ Cancer Treatment and Research‘ series, as stated in the preface to the first volume, is to assemble in a concentrated form selected ingredients of chemothera- peutic progress. These ingredients are to include concepts in therapeutic strategy, pre-clinical studies, development of major classes of compounds, identificatlon of new directions and of landmarks of clinical progress. Thus we do not foresee overlap with series which provide an yearly update of chemotherapy in an encyclopedic manner, or reviews of cancer chemother- apy. Unlike those publications, our volumes are not intended to seek a place in shelve
出版日期Book 1985
關(guān)鍵詞DNA; cancer treatment; carcinoma; cell; transplantation
版次1
doihttps://doi.org/10.1007/978-1-4613-2563-5
isbn_softcover978-1-4612-9610-2
isbn_ebook978-1-4613-2563-5Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightMartinus Nijhoff Publishers, Boston 1985
The information of publication is updating

書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy影響因子(影響力)




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy影響因子(影響力)學(xué)科排名




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy被引頻次




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy被引頻次學(xué)科排名




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy年度引用




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy年度引用學(xué)科排名




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy讀者反饋




書(shū)目名稱Experimental and Clinical Progress in Cancer Chemotherapy讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:02:47 | 只看該作者
Chemotherapy in Osteosarcoma: Advances and Controversies,ablished disease. These developments, however, have not been without controversy [10–13]. The latter emerged principally from a comparison of the results of the new investigations with historical controls. This communication will outline the impact of chemotherapy in osteosarcoma and examine the controversial issues.
板凳
發(fā)表于 2025-3-22 03:24:10 | 只看該作者
地板
發(fā)表于 2025-3-22 07:41:56 | 只看該作者
https://doi.org/10.1007/978-3-642-86867-2enous thiols does not interfere with the immunosuppressive (i.e. myelosuppressive) and carcinostatic properties of CP, which appear to be the consequence of metabolism-dependent formation of the alkylating metabolites of CP, presumably phosphoramide mustard.
5#
發(fā)表于 2025-3-22 11:38:17 | 只看該作者
6#
發(fā)表于 2025-3-22 15:53:03 | 只看該作者
0927-3042 odels; drug classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. Authors were selected on the basis of their ability to provide a critical overview of specific subjects and their involvement in original work. I shall review th
7#
發(fā)表于 2025-3-22 19:08:01 | 只看該作者
8#
發(fā)表于 2025-3-23 00:50:54 | 只看該作者
9#
發(fā)表于 2025-3-23 02:55:39 | 只看該作者
10#
發(fā)表于 2025-3-23 08:16:59 | 只看該作者
Book 1985g classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. Authors were selected on the basis of their ability to provide a critical overview of specific subjects and their involvement in original work. I shall review the aims of
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 18:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南开区| 濮阳县| 老河口市| 茂名市| 黔西县| 旌德县| 凉城县| 玉田县| 方城县| 牙克石市| 井冈山市| 海淀区| 绥滨县| 英德市| 湖南省| 若羌县| 梁河县| 栾川县| 宝丰县| 民乐县| 宝丰县| 大名县| 长泰县| 台南市| 古田县| 大渡口区| 唐山市| 顺昌县| 吴江市| 鱼台县| 松阳县| 龙井市| 镇雄县| 塔城市| 惠东县| 南涧| 扎囊县| 政和县| 十堰市| 太谷县| 常宁市|